Plasma membrane translocation of REDD1 governed by GPCRs contributes to mTORC1 activation

Journal of Cell Science

Volumn 127, Issue 4, 2014, Pages 773-787

  Michel, Grégory ^a   Matthes, Hans W D ^a   Hachet Haas, Muriel ^a   El Baghdadi, Keltouma ^a   de Mey, Jan ^b   Pepperkok, Rainer ^c   Simpson, Jeremy C ^d   Galzi, Jean Luc ^a   Lecat, Sandra ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Faculté de Pharmacie   (France)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Bioluminescence resonance energy transfer; Ca2+ calmodulin signaling pathway; G protein coupled receptors; MTOR; Plasma membrane translocation; REDD1

Indexed keywords

BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CA2+/CALMODULIN SIGNALING PATHWAY; G-PROTEIN-COUPLED RECEPTORS; MTOR; PLASMA MEMBRANE TRANSLOCATION; REDD1;

AMINO ACID SEQUENCE; CALCIUM SIGNALING; CALMODULIN; CELL MEMBRANE; ENZYME ACTIVATION; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN SORTING SIGNALS; PROTEIN TRANSPORT; PROTEINS; RECEPTORS, NEUROKININ-2; TOR SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS;

EID: 84894031924     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.136432     Document Type: Article

References (72)

1. An, S. W., Cha, S. K., Yoon, J., Chang, S., Ross, E. M. and Huang, C. L. (2011). WNK1 promotes PIP2 synthesis to coordinate growth factor and GPCR-Gq signaling. Curr. Biol. 21, 1979-1987.
2. Atwood, B. K., Lopez, J., Wager-Miller, J., Mackie, K. and Straiker, A. (2011). Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis. BMC Genomics 12, 14.
3. Ben Sahra, I., Regazzetti, C., Robert, G., Laurent, K., Le Marchand-Brustel, Y., Auberger, P., Tanti, J. F., Giorgetti-Peraldi, S. and Bost, F. (2011). Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. Cancer Res. 71, 4366-4372.
4. Benitah, J. P., Alvarez, J. L. and Gómez, A. M. (2010). L-type Ca(2+) current in ventricular cardiomyocytes. J. Mol. Cell Cardiol. 48, 26-36.
5. Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W. and Kaelin, W. G., Jr (2004). Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 18, 2893-2904.
6. Bryksin, A. V. and Matsumura, I. (2010). Overlap extension PCR cloning: a simple and reliable way to create recombinant plasmids. Biotechniques 48, 463-465.
7. Busillo, J. M., Armando, S., Sengupta, R., Meucci, O., Bouvier, M. and Benovic, J. L. (2010). Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling. J. Biol. Chem. 285, 7805-7817.
8. Cézanne, L., Lecat, S., Lagane, B., Millot, C., Vollmer, J. Y., Matthes, H., Galzi, J. L. and Lopez, A. (2004). Dynamic confinement of NK2 receptors in the plasma membrane. Improved FRAP analysis and biological relevance. J. Biol. Chem. 279, 45057-45067.
9. Corradetti, M. N., Inoki, K. and Guan, K. L. (2005). The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway. J. Biol. Chem. 280, 9769-9772.
10. Daulat, A. M., Maurice, P. and Jockers, R. (2009). Recent methodological advances in the discovery of GPCR-associated protein complexes. Trends Pharmacol. Sci. 30, 72-78.
11. De Mey, J. R., Kessler, P., Dompierre, J., Cordelières, F. P., Dieterlen, A., Vonesch, J. L. and Sibarita, J. B. (2008). Fast 4D Microscopy. Methods Cell Biol. 85, 83-112.
12. del Toro, R., Prahst, C., Mathivet, T., Siegfried, G., Kaminker, J. S., Larrivee, B., Breant, C., Duarte, A., Takakura, N., Fukamizu, A. et al. (2010). Identification and functional analysis of endothelial tip cell-enriched genes. Blood 116, 4025-4033.
13. DeYoung, M. P., Horak, P., Sofer, A., Sgroi, D. and Ellisen, L. W. (2008). Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev. 22, 239-251.
14. Drake, M. T., Violin, J. D., Whalen, E. J., Wisler, J. W., Shenoy, S. K. and Lefkowitz, R. J. (2008). beta-arrestin-biased agonism at the beta2-adrenergic receptor. J. Biol. Chem. 283, 5669-5676.
15. Edwards, D. R. (1994). Cell signalling and the control of gene transcription. Trends Pharmacol. Sci. 15, 239-244.
16. Ellisen, L. W. (2005). Growth control under stress: mTOR regulation through the REDD1-TSC pathway. Cell Cycle 4, 1500-1502.
17. Ellisen, L. W., Ramsayer, K. D., Johannessen, C. M., Yang, A., Beppu, H., Minda, K., Oliner, J. D., McKeon, F. and Haber, D. A. (2002). REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol. Cell 10, 995-1005.
18. Feng, Q., Zou, X., Lu, L., Li, Y., Liu, Y., Zhou, J. and Duan, C. (2012). The stressresponse gene redd1 regulates dorsoventral patterning by antagonizing Wnt/bcatenin activity in zebrafish. PLoS ONE 7, e52674.
19. Franke, T. F., Kaplan, D. R., Cantley, L. C. and Toker, A. (1997). Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275, 665-668.
20. Friedman, J., Babu, B. and Clark, R. B. (2002). Beta(2)-adrenergic receptor lacking the cyclic AMP-dependent protein kinase consensus sites fully activates extracellular signal-regulated kinase 1/2 in human embryonic kidney 293 cells: lack of evidence for G(s)/G(i) switching. Mol. Pharmacol. 62, 1094-1102.
21. Frost, R. A., Huber, D., Pruznak, A. and Lang, C. H. (2009). Regulation of REDD1 by insulin-like growth factor-I in skeletal muscle and myotubes. J. Cell. Biochem. 108, 1192-1202.
22. Galandrin, S., Oligny-Longpré, G. and Bouvier, M. (2007). The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol. Sci. 28, 423-430.
23. Gao, Z., Chen, T., Weber, M. J. and Linden, J. (1999). A2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. cross-talk between cyclic AMP and protein kinase c pathways. J. Biol. Chem. 274, 5972-5980.
24. Gicquiaux, H., Lecat, S., Gaire, M., Dieterlen, A., Mély, Y., Takeda, K., Bucher, B. and Galzi, J. L. (2002). Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor. J. Biol. Chem. 277, 6645-6655.
25. Hachet-Haas, M., Converset, N., Marchal, O., Matthes, H., Gioria, S., Galzi, J. L. and Lecat, S. (2006). FRETand colocalization analyzer-a method to validate measurements of sensitized emission FRET acquired by confocal microscopy and available as an ImageJ Plug-in. Microsc. Res. Tech. 69, 941-956.
26. Hachet-Haas, M.,Balabanian, K.,Rohmer, F., Pons, F., Franchet,C., Lecat, S., Chow, K. Y., Dagher, R., Gizzi, P., Didier, B. et al. (2008). Small neutralizing molecules to inhibit actions of the chemokine CXCL12. J. Biol. Chem. 283, 23189-23199.
27. Hains, M. D., Wing, M. R., Maddileti, S., Siderovski, D. P. and Harden, T. K. (2006). Galpha12/13-and rho-dependent activation of phospholipase C-epsilon by lysophosphatidic acid and thrombin receptors. Mol. Pharmacol. 69, 2068-2075.
28. Haribabu, B., Richardson, R. M., Fisher, I., Sozzani, S., Peiper, S. C., Horuk, R., Ali, H. and Snyderman, R. (1997). Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J. Biol. Chem. 272, 28726-28731.
29. Heo, W. D., Inoue, T., Park, W. S., Kim, M. L., Park, B. O., Wandless, T. J. and Meyer, T. (2006). PI(3,4,5)P3 and PI(4,5)P2 lipids target proteins with polybasic clusters to the plasma membrane. Science 314, 1458-1461.
30. Hermans, E. (2003). Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors. Pharmacol. Ther. 99, 25-44.
31. Horak, P., Crawford, A. R., Vadysirisack, D. D., Nash, Z. M., DeYoung, M. P., Sgroi, D. and Ellisen, L. W. (2010). Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc. Natl. Acad. Sci. USA 107, 4675-4680.
32. Hudson, C. C., Oakley, R. H., Sjaastad, M. D. and Loomis, C. R. (2006). Highcontent screening of known G protein-coupled receptors by arrestin translocation. Methods Enzymol. 414, 63-78.
33. Inoki, K., Li, Y., Zhu, T., Wu, J. andGuan, K. L. (2002). TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4, 648-657.
34. Jiang, H., Kuang, Y., Wu, Y., Smrcka, A., Simon, M. I. and Wu, D. (1996). Pertussis toxin-sensitive activation of phospholipase C by the C5a and fMet-Leu-Phe receptors. J. Biol. Chem. 271, 13430-13434.
35. Katiyar, S., Liu, E., Knutzen, C. A., Lang, E. S., Lombardo, C. R., Sankar, S., Toth, J. I., Petroski, M. D., Ronai, Z. and Chiang, G. G. (2009). REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligase. EMBO Rep. 10, 866-872.
36. Kimball, S. R., Do, A. N., Kutzler, L., Cavener, D. R. and Jefferson, L. S. (2008). Rapid turnover of the mTOR complex 1 (mTORC1) repressor REDD1 and activation of mTORC1 signaling following inhibition of protein synthesis. J. Biol. Chem. 283, 3465-3475.
37. Lecat, S., Ouédraogo, M., Cherrier, T., Noulet, F., Rondé , P., Glasser, N., Galzi, J. L., Mely, Y., Takeda, K. and Bucher, B. (2011). Contribution of a tyrosinebased motif to cellular trafficking of wild-type and truncated NPY Y(1) receptors. Cell. Signal. 23, 228-238.
38. Lin, L., Stringfield, T. M., Shi, X. and Chen, Y. (2005). Arsenite induces a cell stressresponse gene, RTP801, through reactive oxygen species and transcription factors Elk-1 and CCAAT/enhancer-binding protein. Biochem. J. 392, 93-102.
39. Linden, J., Thai, T., Figler, H., Jin, X. and Robeva, A. S. (1999). Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. Mol. Pharmacol. 56, 705-713.
40. Loening, A. M., Fenn, T. D., Wu, A. M. and Gambhir, S. S. (2006). Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output. Protein Eng. Des. Sel. 19, 391-400.
41. Malagelada, C., Ló pez-Toledano, M. A., Willett, R. T., Jin, Z. H., Shelanski, M. L. and Greene, L. A. (2011). RTP801/REDD1 regulates the timing of cortical neurogenesis and neuron migration. J. Neurosci. 31, 3186-3196.
42. Mata, M. A., Satterly, N., Versteeg, G. A., Frantz, D., Wei, S., Williams, N., Schmolke, M., Peña-Llopis, S., Brugarolas, J., Forst, C. V. et al. (2011). Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor. Nat. Chem. Biol. 7, 712-719.
43. Meffre, J., Chaumont-Dubel, S., Mannoury la Cour, C., Loiseau, F., Watson, D. J., Dekeyne, A., Séveno, M., Rivet, J. M., Gaven, F., Déléris, P. et al. (2012). 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. EMBO Mol. Med. 4, 1043-1056.
44. Miyazaki, M. and Esser, K. A. (2009). REDD2 is enriched in skeletal muscle and inhibits mTOR signaling in response to leucine and stretch. Am. J. Physiol. 296, C583-C592.
45. Montmayeur, J. P., Barr, T. P., Kam, S. A., Packer, S. J. and Strichartz, G. R. (2011). ET-1 induced Elevation of intracellular calcium in clonal neuronal and embryonic kidney cells involves endogenous endothelin-A receptors linked to phospholipase C through Ga(q/11). Pharmacol. Res. 64, 258-267.
46. Morrison, D. K. (2009). The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol. 19, 16-23.
47. Musnier, A., Blanchot, B., Reiter, E. and Crépieux, P. (2010). GPCR signalling to the translation machinery. Cell. Signal. 22, 707-716.
48. Noseda, R., Belin, S., Piguet, F., Vaccari, I., Scarlino, S., Brambilla, P., Martinelli Boneschi, F., Feltri, M. L., Wrabetz, L., Quattrini, A. et al. (2013). DDIT4/REDD1/RTP801 is a novel negative regulator of Schwann cell myelination. J. Neurosci. 33, 15295-15305.
49. Ouedraogo, M., Lecat, S., Rochdi, M. D., Hachet-Haas, M., Matthes, H., Gicquiaux, H., Verrier, S., Gaire, M., Glasser, N., Mély, Y. et al. (2008). Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitization. Traffic 9, 305-324.
50. Regazzetti, C., Bost, F., Le Marchand-Brustel, Y., Tanti, J. F. and Giorgetti-Peraldi, S. (2010). Insulin induces REDD1 expression through hypoxiainducible factor 1 activation in adipocytes. J. Biol. Chem. 285, 5157-5164.
51. Regazzetti, C., Dumas, K., Le Marchand-Brustel, Y., Peraldi, P., Tanti, J. F. and Giorgetti-Peraldi, S. (2012). Regulated in development and DNA damage responses 21 (REDD1) protein contributes to insulin signaling pathway in adipocytes. PLoS ONE 7, e52154.
52. Reiling, J. H. and Hafen, E. (2004). The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila. Genes Dev. 18, 2879-2892.
53. Roux, P. P., Shahbazian, D., Vu, H., Holz, M. K., Cohen, M. S., Taunton, J., Sonenberg, N. and Blenis, J. (2007). RAS/ERK signaling promotes sitespecific ribosomal protein S6 phosphorylation via RSK and stimulates capdependent translation. J. Biol. Chem. 282, 14056-14064.
54. Rozengurt, E. (2007). Mitogenic signaling pathways induced by G proteincoupled receptors. J. Cell. Physiol. 213, 589-602.
55. Rozengurt, E., Sinnett-Smith, J. and Kisfalvi, K. (2010). Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer. Clin. Cancer Res. 16, 2505-2511.
56. Savino, T. M., Gébrane-Younès, J., De Mey, J., Sibarita, J. B. and Hernandez-Verdun, D. (2001). Nucleolar assembly of the rRNA processing machinery in living cells. J. Cell Biol. 153, 1097-1110.
57. Schwarzer, R., Tondera, D., Arnold, W., Giese, K., Klippel, A. and Kaufmann, J. (2005). REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase. Oncogene 24, 1138-1149.
58. Scuderi, A., Simin, K., Kazuko, S. G., Metherall, J. E. and Letsou, A. (2006). scylla and charybde, homologues of the human apoptotic gene RTP801, are required for head involution in Drosophila. Dev. Biol. 291, 110-122.
59. Shaw, G., Morse, S., Ararat, M. and Graham, F. L. (2002). Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16, 869-871.
60. Shenoy, S. K., Drake, M. T., Nelson, C. D., Houtz, D. A., Xiao, K., Madabushi, S., Reiter, E., Premont, R. T., Lichtarge, O. and Lefkowitz, R. J. (2006). betaarrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J. Biol. Chem. 281, 1261-1273.
61. Shoshani, T., Faerman, A., Mett, I., Zelin, E., Tenne, T., Gorodin, S., Moshel, Y., Elbaz, S. M., Budanov, A., Chajut, A. et al. (2002). Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol. Cell Biol. 7, 2283-2293.
62. Simpson, J. C., Wellenreuther, R., Poustka, A., Pepperkok, R. and Wiemann, S. (2000). Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. EMBO Rep. 1, 287-292.
63. Sofer, A., Lei, K., Johannessen, C.M. and Ellisen, L.W. (2005). Regulation ofmTOR and cell growth in response to energy stress by REDD1. Mol. Cell. Biol. 25, 5834-5845.
64. Stallaert, W., Dorn, J. F., van der Westhuizen, E., Audet, M. and Bouvier, M. (2012). Impedance responses reveal b2-adrenergic receptor signaling pluridimensionality and allow classification of ligands with distinct signaling profiles. PLoS ONE 7, e29420.
65. Teruel, M. N. and Meyer, T. (2000). Translocation and reversible localization of signaling proteins: a dynamic future for signal transduction. Cell 103, 181-184.
66. Tumaneng, K., Russell, R. C. and Guan, K. L. (2012). Organ size control by Hippo and TOR pathways. Curr. Biol. 22, R368-R379.
67. Varghese, B. V., Koohestani, F., McWilliams, M., Colvin, A., Gunewardena, S., Kinsey, W. H., Nowak, R. A., Nothnick, W. B. and Chennathukuzhi, V. M. (2013). Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway. Proc. Natl. Acad. Sci. USA 110, 2187-2192.
68. Vega-Rubin-de-Celis, S., Abdallah, Z., Kinch, L., Grishin, N. V., Brugarolas, J. and Zhang, X. (2010). Structural analysis and functional implications of the negative mTORC1 regulator REDD1. Biochemistry 49, 2491-2501.
69. Vollmer, J. Y., Alix, P., Chollet, A., Takeda, K. and Galzi, J. L. (1999). Subcellular compartmentalization of activation and desensitization of responses mediated by NK2 neurokinin receptors. J. Biol. Chem. 274, 37915-37922.
70. Wauson, E. M., Zaganjor, E., Lee, A. Y., Guerra, M. L., Ghosh, A. B., Bookout, A. L., Chambers, C. P., Jivan, A., McGlynn, K., Hutchison, M. R. et al. (2012). The G protein-coupled taste receptor T1R1/T1R3 regulates mTORC1 and autophagy. Mol. Cell 47, 851-862.
71. Yu, F. X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H. et al. (2012). Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780-791.
72. Zacharias, D. A., Violin, J. D., Newton, A. C. and Tsien, R. Y. (2002). Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 296, 913-916.